Wyszukano: CELL VIABILITY
243 wyniki/ów wyszukiwania
Cell culture
/cms/bioprocessing_upstream_processing_cell_culture
Cell culture Both autologous and allogeneic cells are obtained from donors utilizing methods including but not limited to apheresis aspirates and surgical biopsies. The donor cells of interest are processed to remove undesirable contaminants and p...
Cell Factories
/cms/cell_to_therapy_cell_factories
Cell Factories Featured Solutions From bench and beyond obtain faster results and lot-to-lot consistency with Thermo Scientific Nunc Cell Factory systems. A proven solution for commercialisation of proteins vaccines and advanced therapeutics proce...
Cell Growth
/cms/featured_solutions_cell_growth
Cell Growth Keep your cells fit and happy by providing them optimal growth conditions. Select cell culture plastics and nutrients you can rely on. Ensure sterility as well as precise temperature and gas control during incubation and handling. Noth...
3D Cell Culture
/cms/featured_solutions_3d_cell_culture
3D Cell Culture Putting your cells in 'in-vivo like' environments! There is no doubt that in vitro testing models that better mimic in vivo conditions will give results of greater physiological relevance. More than this 3D cell culture solutions a...
PG1698-PJT2892-COL05537-RO-SUT-RS-App-Note-Mesenchymal-stem-cells-CF-systems-Global-12-18-17.indd
/m-pl.vwr.com/pl_PL/images/App-Note-Mesenchymal-stem-cells-CF-systems-COL0553.pdf
PG1698-PJT2892-COL05537-RO-SUT-RS-App-Note-Mesenchymal-stem-cells-CF-systems-Global-12-18-17.indd Abstract Thermo Scientific™ Nunc™ Cell Factory™ systems are an effective format for the easy and rapid expansion of human mesenchymal stem cells (hMS...
Upstream processing for cell therapy
/cms/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
@@NUMMER 8090145@@
/m-pl.vwr.com/pl_PL/images/AP_A8366_Myco4.pdf
@@NUMMER 8090145@@ Myco-4 For the treatment of Mycoplasma-infected cells Product code A8366 Description Contamination of cell cultures by mycoplasma is a common problem. Mycoplasma contamination causes biochemical changes as well as changes in the...
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
Cell Therapy Products, Workflow & Research Services
/cms/bioprocessing_cell_therapy
Cell Therapy Products Workflow & Research Services Cell therapies encompass several approaches that require the manipulation of donor tissue both autologous and allogeneic to obtain desired cells and tissues. These cells and tissues are then used ...
Cell Culture Surface Selection: Achieving optimal growth and harvesting of your cells
/cms/cell_culture_surface_selection
Cell Culture Surface Selection: Achieving optimal growth and harvesting of your cells Webinar Tuesday 5th October 2021 15:00 to 16:00 CEST (Berlin Paris Madrid) Replay Cell Culture is a key step in a wide variety of life science workflows. To help...
COL06663_Cell_Factory_BOD_PDF_Flyer.indd
/m-pl.vwr.com/pl_PL/images/Flyer-Cell-Factory-COL06663-May-2018.pdf
COL06663_Cell_Factory_BOD_PDF_Flyer.indd Cell Factory systems The Thermo Scientific™ Nunc™ Cell Factory™ system is a robust and easy-to-use cell culture platform for applications in the production of human and animal vaccines therapeutic proteins ...
No Longer Tasked with Cell Bank Management, Scientists Gain Time for Research
/cms/avantor_services_success_stories_cell_bank_management
No Longer Tasked with Cell Bank Management Scientists Gain Time for Research Twoja rola Twoje wyzwanie Nasze usługi serwisowe Zasoby O nas Skontaktuj się z nami Challenge The pace of research is accelerating but new aggressive discovery timelines ...
Promise and Potential: Cell Therapies for Pediatric Patients
/cms/cell_therapies_pediatric_patients
Promise and Potential: Cell Therapies for Pediatric Patients Interview with Professor Dr. Peter Bader Head of the Division for Stem Cell Transplantation and Immunology Department for Children and Adolescents University Hospital Frankfurt Goethe Un...
~~29188433AA Production of recombinant monoclonal an~~
/m-pl.vwr.com/pl_PL/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~cell bank management eu~~
/m-pl.vwr.com/pl_PL/images/cell_bank_management_eu.pdf
SucceSS Story cell Bank ManageMent Problem The pace of research is accelerating. New aggressive discovery timelines mean that scientists face increasing pressure to deliver results quickly. As part of continuous innovation efforts a team at one of...
33 - 48 of 243